Ipca Laboratories Ltd. Financials: Check Share Price, Balance Sheet, Annual Report and Quarterly Results for Company Analysis

Ipca Laboratories Ltd. is a leading pharmaceutical company in India that specializes in the manufacturing and marketing of formulations and active pharmaceutical ingredients (APIs).  We will take a closer look at Ipca Laboratories Ltd. stock analysis page and explore various aspects of the company that can help long-term investors make informed investment decisions.

Ipca Laboratories Ltd Share Price

Ipca Laboratories Ltd.'s share price has been on a steady upward trend in recent years. The company's strong financial performance and growth prospects have attracted a lot of investor interest, leading to an increase in demand for its shares. Investors can track the company's share price on Ticker's stock analysis page, which provides real-time updates on the stock's performance.

Ipca Laboratories Ltd Balance Sheet

Ipca Laboratories Ltd.'s balance sheet is a reflection of its financial health and stability. The company has a strong balance sheet, with a healthy mix of debt and equity. Ticker pre-built screening tools such as DCF Analysis, BVPS Analysis, Earnings multiple approach and DuPont analysis can help investors evaluate the company's financial performance and calculate its fair value. Investors can access the company's balance sheet on Ticker's stock analysis page, along with other financial data such as quarterly results and profit and loss statements.

Ipca Laboratories Ltd Annual Report

Ipca Laboratories Ltd.'s annual report provides a comprehensive overview of the company's performance over the past year. The report includes detailed information on the company's financials, operations, and growth prospects. Investors can download the company's annual report from Ticker's stock analysis page. The report can help investors gain a better understanding of the company's business model, competitive landscape, and growth potential.

Ipca Laboratories Ltd Dividend

Ipca Laboratories Ltd. has a track record of paying dividends to its shareholders. The company's dividend policy is based on its financial performance and growth prospects. Investors can access the company's dividend history on Ticker's stock analysis page. 

Ipca Laboratories Ltd Quarterly Result

Ipca Laboratories Ltd.'s quarterly results provide a snapshot of the company's financial performance over the past quarter. The results include information on the company's revenue, profits, and margins. Investors can download the company's quarterly results from Ticker's stock analysis page. Ticker pre-built screening tools such as DCF Analysis, BVPS Analysis, Earnings multiple approach and DuPont analysis can help investors evaluate the company's financial performance and calculate its fair value.

Ipca Laboratories Ltd Stock Price

Ipca Laboratories Ltd.'s stock price is a reflection of its financial performance and growth prospects. The company's stock price is influenced by various factors such as market trends, investor sentiment, and the company's financials. Investors can track the company's stock price on Ticker's stock analysis page, which provides real-time updates on the stock's performance.

Ipca Laboratories Ltd Price Chart

Ipca Laboratories Ltd.'s price chart provides a visual representation of the company's stock price movement over a period. The chart includes information on the company's stock price, volume, and trends. Investors can access the company's price chart on Ticker's stock analysis page. The chart can help investors gain insights into the company's stock price movement and identify trends.

Ipca Laboratories Ltd News

Ipca Laboratories Ltd.'s news section provides updates on the company's latest developments and announcements. The section includes information on the company's product launches, partnerships, and collaborations. Investors can access the company's news section on Ticker's stock analysis page. The news section can help investors stay updated on the company's latest developments and make informed investment decisions.

Ipca Laboratories Ltd Concall Transcripts

Ipca Laboratories Ltd.'s concall transcripts provide a detailed account of the company's earnings conference call. The transcripts include information on the company's financial performance, growth prospects, and future plans. Investors can download the company's concall transcripts from Ticker's stock analysis page. The transcripts can help investors gain insights into the company's performance and future prospects.

Ipca Laboratories Ltd Investor Presentations

Ipca Laboratories Ltd.'s investor presentations provide a detailed overview of the company's business model, operations, and growth prospects. The presentations include information on the company's financials, product portfolio, and competitive landscape. Investors can download the company's investor presentations from Ticker's stock analysis page. The presentations can help investors gain a better understanding of the company's business model and growth potential.

Ipca Laboratories Ltd Promoters

Ipca Laboratories Ltd.'s promoters are the key drivers of the company's growth and success. The promoters have a significant stake in the company and are actively involved in its operations and decision-making. Investors can access information on the company's promoters on Ticker's stock analysis page. The information can help investors evaluate the promoters' track record and their contribution to the company's growth.

Ipca Laboratories Ltd Shareholders

Ipca Laboratories Ltd.'s shareholders are the owners of the company and have a stake in its financial performance and growth prospects. The company has a diverse shareholder base, including institutional investors and retail investors. Investors can access information on the company's shareholders on Ticker's stock analysis page. The information can help investors evaluate the company's shareholder base and their contribution to the company's growth.

Ipca Laboratories Ltd ROCE

Ipca Laboratories Ltd ROCE (Return on Capital Employed) measures the profitability and efficiency of the company's capital investments. It indicates how well the company generates returns from its capital employed. The ROCE can be obtained from the financials table or ratio section provided on this page.

Ipca Laboratories Ltd EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of Ipca Laboratories Ltd provides insights into the company's operational profitability. This metric reflects the company's ability to generate earnings from its core business operations, excluding non-operating factors. For detailed EBITDA data, refer to the above financials table or ratio section.

Ipca Laboratories Ltd DPS

Ipca Laboratories Ltd DPS (Dividends Per Share) represents the amount of cash distributed to shareholders for each share held. It allows investors to assess the company's dividend policy and potential returns. The DPS information for Ipca Laboratories Ltd can be found in the above financials table or ratio section.

Ipca Laboratories Ltd EPS

The EPS (Earnings Per Share) of Ipca Laboratories Ltd is a crucial metric that shows the company's profitability on a per-share basis. It is obtained by dividing the company's earnings by the total outstanding shares. Investors can find the EPS data for Ipca Laboratories Ltd in the above financials table or ratio section on this page. 

Ipca Laboratories Balance Sheet Examination

Ipca Laboratories has demonstrated a strengthening financial position over the years, as shown by the data from March 2020 to March 2024.

Stability in Ipca Laboratories' Share Capital

Ipca Laboratories maintained a stable share capital at Rs. 25.37 Cr from March 2021 to March 2024, indicating confidence in the company's governance and future prospects.

Growth in Ipca Laboratories' Total Reserves

The total reserves of Ipca Laboratories have consistently grown from Rs. 3,652.27 Cr in March 2020 to Rs. 6,323.34 Cr in March 2024, underscoring the company's ability to accumulate retained earnings and strengthen its financial reserves.

Ipca Laboratories' Debt Management

Borrowings experienced fluctuations, reaching Rs. 651.78 Cr in March 2023 before decreasing to Rs. 542.19 Cr by March 2024. This suggests a strategic approach to leveraging and debt management in line with its operational needs.

Asset Base Expansion for Ipca Laboratories

Ipca Laboratories' total asset value has seen an upward trend, standing at Rs. 8,659.27 Cr in March 2024. Significant growth has been seen in investments, which more than quintupled to Rs. 2,243.56 Cr during the same period, reflecting strategic asset allocation.

The provided data offers a standalone balance sheet analysis of Ipca Laboratories without recommendations for trading.

When conducting stock screening, investors can glean insights from this data, integrating it with broader market analysis including NSE BSE indices and sector-based performance metrics.